Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation. - Wikidata - wikimedia - TriplyDB

Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.

Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.

http://www.wikidata.org/entity/Q46747580

about

Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Tau and tauopathies 3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease.Genomic survey of prepulse inhibition in mouse chromosome substitution strains.P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.Knock-out and transgenic mouse models of tauopathies.Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy Vaccination as a therapeutic approach to Alzheimer's disease.Murine models of Alzheimer's disease and their use in developing immunotherapies.Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.Are tau aggregates toxic or protective in tauopathies?Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17.Biomarker identification for diagnosis of Alzheimer's disease.

P2860

Q24645703-993CD91B-05AF-4368-A339-CF465D4F8740 Q27027415-9332E21A-E223-4EEB-8A57-A0FE1C972D7B Q27334236-F71DA02C-63F5-4DC5-8555-D7A07972D006 Q30444790-876DAFBD-1168-412D-9AC2-ADF25711BD01 Q30450693-E83C776B-CDBA-4BF0-AC33-0B98AB65180A Q30475074-191CFA03-2AB9-4A82-A809-6C109674269B Q30480843-7EC640AB-0EF3-43AD-975E-155F8140051E Q30497471-7FC86FDE-6DCB-4DCD-BA28-6449CB186F36 Q30667424-296EB56F-008D-415C-B7FB-E961C75A5344 Q33304015-85B00972-1E95-467C-9F97-F91A3A01F6A5 Q34292532-84F3EC72-BF51-4BAA-A9F2-6A0DE750A512 Q36859244-38B83A94-8622-45A5-BF8E-B5C139ED15C8 Q37399956-0972579E-432A-4F0E-BC13-0FA4C7DD71B4 Q37544904-A356823E-B1F5-4FC9-B7EC-BE0914AFF173 Q37630546-10CBC8F0-032C-45DD-826A-3F348BCDFDD7 Q37655247-A94BF2F7-313B-4AA1-9F01-499BF237604E Q37663194-AA2423E2-F4C0-4573-886C-5A59873EB265 Q37681432-78C9B218-B586-414D-8FAA-562C8EFBBFE8 Q37752915-5089324F-4383-4593-A53A-983A027204D0 Q38271896-C54A5A8E-9BF4-4360-A3BE-502CA6A6CCE1 Q42024199-56BA7605-E38A-42D0-B6D8-9BD153365648 Q45719870-0D09EB12-C76F-4606-8E8B-C8B7F26F9CBB Q53480286-BEFB0141-30F9-4ABF-A650-614CBECC3D45

P2860

Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.

http://www.wikidata.org/entity/Q46747580

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Transgenic mice expressing mut ...... rofibrillary tangle formation.

@en

Transgenic mice expressing mutant

@nl

type

label

Transgenic mice expressing mut ...... rofibrillary tangle formation.

@en

Transgenic mice expressing mutant

@nl

prefLabel

Transgenic mice expressing mut ...... rofibrillary tangle formation.

@en

Transgenic mice expressing mutant

@nl

P1433

Q46747580-D2012634-3BDB-4E41-A723-06EC74283255

P1476

Q46747580-F0786CE4-709B-4FD7-AFCD-ED38E62474F9

P2093

Q46747580-0FA1DF9D-12E7-4F69-8299-BE31B7A8E791

Q46747580-248E25C0-B96F-4819-A16F-F1DF4E042668

Q46747580-42F5628E-0856-4036-803B-65F88901BC8B

Q46747580-4F8FDC14-1E83-4897-8A41-5601F0CFBB4A

Q46747580-9961B8C9-3B7A-4EC3-B601-60078B5243BB

Q46747580-D2EEDA38-8E05-4A90-8E68-8CF324CA90E8

Q46747580-DF0C393D-891C-42C6-9880-A34AE16C1D77

P2860

Q46747580-01B604A9-CDBD-46D6-B20E-DE7BE8AC45DD

Q46747580-0C7C6D25-CB6E-4AE5-BA43-7F4FA51EB684

Q46747580-0FE954B1-0291-43B3-9FCB-DC9E10F8DAB4

Q46747580-124FD190-D44B-4CF5-82F0-2960A9B85C33

Q46747580-158CAFF3-A856-4327-93D4-559D0922D309

Q46747580-1923DD2B-87D0-4724-80AA-09B92CAF818D

Q46747580-1AB4A46E-996D-4218-B4F0-4A6BB98872BF

Q46747580-23B5CDDA-C40E-47E8-B003-E39EE7687450

Q46747580-323CDD5D-60D4-4A11-9217-BDCAD7751F66

Q46747580-3C3A015D-5944-43FF-BE50-EF8D36B26E06

P304

Q46747580-B959D3AC-E326-4BC3-895F-E3C8650597E9

P31

Q46747580-80F34BCA-244B-4A90-A2DF-734333D55BDE

P356

Q46747580-42313DA4-45AB-4FF5-94A6-5D92BF00259F

P407

Q46747580-1A97FB15-C803-4704-92E3-1B3E4F7751BB

P433

Q46747580-B9381D35-635C-4A86-B1BB-AC8A367D3A1C

P478

Q46747580-86CC745A-C492-4AFA-A620-5A0867B6889F

P577

Q46747580-DB402758-5F4C-41AA-85E6-0141FF2C26D3

P5875

Q46747580-562F8B82-2BED-423A-8A19-2CED8D8D0F4B

P698

Q46747580-D976CF84-997C-42B2-B227-4B27C6AD9374

P356

J.FEBSLET.2005.09.047

P1433

P1476

Transgenic mice expressing mut ...... rofibrillary tangle formation.

@en

P2093

Chikako Tanaka

http://www.w3.org/2001/XMLSchema#string

Hiroshi Mori

http://www.w3.org/2001/XMLSchema#string

Naoaki Saito

http://www.w3.org/2001/XMLSchema#string

Nobutaka Doe

http://www.w3.org/2001/XMLSchema#string

Shogo Matsuyama

http://www.w3.org/2001/XMLSchema#string

Taizo Taniguchi

http://www.w3.org/2001/XMLSchema#string

Yoshihisa Kitamura

http://www.w3.org/2001/XMLSchema#string

P2860

A synaptic model of memory: long-term potentiation in the hippocampus

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

Place navigation impaired in rats with hippocampal lesions

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

Tau filament formation in transgenic mice expressing P301L tau.

P304

5704-5712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FEBSLET.2005.09.047

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

579

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7547388

http://www.w3.org/2001/XMLSchema#string

P698

16219306

http://www.w3.org/2001/XMLSchema#string